Mineralys Therapeutics, Inc.
Industry: Life Sciences ・ $MLYS on Nasdaq
Insider Sale
+$1,500
-0.15%
Shares
Shares Volume: 100 Shares
Average Share Price: $15
INSIDER
Rodman David Malcom
Chief Medical Officer (Officer)
reported on May 10 2024
traded on May 9 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
NEW SHARES OWNERSHIP AMOUNT | 66,997 |
PURCHASES/SALES 1Y | 0 / 2 |
P/S VALUE RATIO | N/A |
AVERAGE SALE VALUE | $1,498,793.94 |
INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 1 |
PURCHASES/SALES 1Y | 5 / 2 |
P/S VALUE RATIO | 2.537 |
AVERAGE SALE VALUE | $1,498,793.94 |
COMPANY PREVIOUS TRADES |